NOV 19, 2015 03:26 PM PST

IFN-Ɣ Beats Ebola

WRITTEN BY: Kerry Evans
1 8 1554
The Ebola outbreak in West Africa has claimed nearly 12,000 lives since 2014, leaving researchers scrambling to develop effective vaccines and therapies.  University of Iowa researchers have a possible solution, however.  They want to treat Ebola using gamma interferon (IFN-?).

Ebola is transmitted by direct contact with infected blood and body fluids.  Symptoms of infection appear between 2 and 21 days after exposure and include fever, severe headache, vomiting, diarrhea, and hemorrhaging.  In most cases, the mortality rate is 50%.
 
Symptoms appear  2 to 21 days after infection.
Ebola infection occurs in two stages.  First, the virus infects macrophages and dendritic cells in the spleen, lymph nodes, and liver.  Second, after replicating in these cells for 3 to 4 days, the virus is shed into the bloodstream where it goes on to infect multiple other cell types.  Since IFN-? is known to activate macrophages and induce an antiviral state, the group reasoned that IFN-? treatment might inhibit Ebola during the first stage of infection.  

According to study author Wendy Maury, Ebola “goes from an early stage with a very targeted infection of only these few cell types (macrophages and dendritic cells), to everything being infected … we think what’s happening with gamma interferon is that it’s targeting macrophages and blocking the infection of those initial cell targets so you don’t get the second round of infection”.

The group infected mice with a mouse-adapted "Ebola virus" (vesicular stomatitis virus expressing Ebola surface glycoproteins), then treated them with gamma interferon.  When treated up to 24 h after infection, the mice were completely protected.  The group then investigated the mechanism by which IFN-? protected cells from the virus.  They identified 160 genes that were upregulated in macrophages by IFN-? treatment.  When a handful of these genes were upregulated experimentally, they helped ward off infection.  

The only drawback is that IFN-? treatment is probably only effective at the early stage of infection. According to Maury, “My guess is that if you delay the gamma interferon too much, you miss this window of opportunity to block the infection in macrophage cells and the gamma interferon can no longer provide protection”.

Sources: Science Daily, PLOS Pathogens, WHO, CDC, Wikipedia
 
About the Author
  • Kerry received a doctorate in microbiology from the University of Arkansas for Medical Sciences.
You May Also Like
MAY 09, 2018
Microbiology
MAY 09, 2018
What we can Learn From Viruses that Infect Bacteria
Phages are viruses that infect bacteria; scientists have found that the same phage can have a markedly different effect on different kinds of bacteria.
MAY 16, 2018
Immunology
MAY 16, 2018
Antibodies Neutralize Two Different Hemorrhagic Fever Viruses
Scientists have found evidence for potential antibody-based therapeutics to treat more than one hemorrhagic fever virus at once. From Harvard Medical Schoo
MAY 21, 2018
Cancer
MAY 21, 2018
Malarial Organism Characteristics Leads Researchers To Potential Cancer Therapeutic Target
The malarial parasite expresses a protein, VAR2CSA, that binds to chondroitin sulfate (CS) found on both placental and cancer tissues. Recombinant rVAR2 could be used to target drugs to CS.
JUN 10, 2018
Microbiology
JUN 10, 2018
Killer Antibiotic-resistant Pathogen Isolated in the US
For decades, people have relied on antibiotics to treat microbial infections, but that is changing.
JUN 23, 2018
Microbiology
JUN 23, 2018
In a First, Keystone Virus Sickens a Person
A teenage boy in North Central Florida presented with symptoms that defied diagnosis.
AUG 05, 2018
Microbiology
AUG 05, 2018
The War Beneath Our Feet
The bacteria living in the soils of Earth seem locked in battle with the fungi there.
Loading Comments...